Autor: |
Rao HW; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Zhao TL; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Wang L; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Deng HD; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Zhang YP; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., You Y; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Wang ZH; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Zhao JQ; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn., Yuan WC; Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China. zhaojianqiang@cdu.edu.cn. |